Skip to main content

Peer Review reports

From: Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial

Original Submission
15 Oct 2021 Submitted Original manuscript
22 Feb 2022 Reviewed Reviewer Report - Bernard Surial
8 Mar 2022 Reviewed Reviewer Report
22 Apr 2022 Author responded Author comments - Kristin Baltrusaitis
Resubmission - Version 2
22 Apr 2022 Submitted Manuscript version 2
26 Apr 2022 Author responded Author comments - Kristin Baltrusaitis
Resubmission - Version 3
26 Apr 2022 Submitted Manuscript version 3
27 Apr 2022 Author responded Author comments - Kristin Baltrusaitis
Resubmission - Version 4
27 Apr 2022 Submitted Manuscript version 4
11 May 2022 Reviewed Reviewer Report - Bernard Surial
25 May 2022 Reviewed Reviewer Report
1 Jun 2022 Author responded Author comments - Kristin Baltrusaitis
Resubmission - Version 5
1 Jun 2022 Submitted Manuscript version 5
Publishing
17 Jun 2022 Editorially accepted
20 Jul 2022 Article published 10.1186/s12879-022-07608-8

You can find further information about peer review here.

Back to article page